Caricamento...
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial
PURPOSE: Precision medicine trials constitute a precious source of molecular data with prospective clinical annotations allowing the exploration of patients’ subpopulations according to specific clinical or biological questions. Using the SHIVA01—the first randomized trial comparing molecularly targ...
Salvato in:
| Pubblicato in: | JCO Precis Oncol |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Clinical Oncology
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7450915/ https://ncbi.nlm.nih.gov/pubmed/32914004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00048 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|